Zobrazeno 1 - 10
of 855
pro vyhledávání: '"A H, Rubenstein"'
Autor:
Anna Tavakkoli, Amit G. Singal, Akbar K. Waljee, James M. Scheiman, Caitlin C. Murphy, Sandi L. Pruitt, Lei Xuan, Richard S. Kwon, Ryan J. Law, Grace H. Elta, Phyllis Wright‐Slaughter, Thomas S. Valley, Nisa Kubiliun, Hari Nathan, Joel H. Rubenstein, B. Joseph Elmunzer
Publikováno v:
Cancer Medicine, Vol 8, Iss 7, Pp 3420-3427 (2019)
Abstract Background Pancreatic cancer is projected to become the second leading cause of cancer‐related deaths by 2030. Endoscopic retrograde cholangiopancreatography (ERCP) is recommended as first‐line therapy for biliary decompression in pancre
Externí odkaz:
https://doaj.org/article/dbb6d5f3376a4abea1e1ef846105e335
Publikováno v:
American Journal of Gastroenterology.
Autor:
Jing Chen, Yang Jiang, Tse-Shao Chang, Joel H. Rubenstein, Richard S. Kwon, Erik J. Wamsteker, Anoop Prabhu, Lili Zhao, Henry D. Appelman, Scott R. Owens, David G. Beer, D. Kim Turgeon, Eric J. Seibel, Thomas D. Wang
Publikováno v:
Endoscopy. 54:1198-1204
Background Esophageal adenocarcinoma (EAC) is a molecularly heterogeneous disease with poor prognosis that is rising rapidly in incidence. We aimed to demonstrate specific binding by a peptide heterodimer to Barrett’s neoplasia in human subjects. M
Autor:
E. Georg Luebeck, Chin Hur, Joel H. Rubenstein, Rafael Meza, Thomas L. Vaughan, John M. Inadomi, Kit Curtius, William D. Hazelton
Figure S2. Male/Female EAC incidence
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::10aeb9069f87c5fb0a03193abcde5f30
https://doi.org/10.1158/1055-9965.22436158
https://doi.org/10.1158/1055-9965.22436158
Cancer screening and early detection efforts have been partially successful in reducing incidence and mortality, but many improvements are needed. Although current medical practice is informed by epidemiologic studies and experts, the decisions for g
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::15e730b102dc8efcc18d40cd7d8c99b0
https://doi.org/10.1158/0008-5472.c.6512467
https://doi.org/10.1158/0008-5472.c.6512467
Autor:
E. Georg Luebeck, Chin Hur, Joel H. Rubenstein, Rafael Meza, Thomas L. Vaughan, John M. Inadomi, Kit Curtius, William D. Hazelton
Background: U.S. esophageal adenocarcinoma (EAC) incidence increased over 5-fold between 1975 and 2009. Symptomatic gastroesophageal reflux disease (sGERD) elevates the risk for EAC. However, a simple calculation suggests that changes in sGERD preval
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::50b5ce27f164943083487bc95649e5fa
https://doi.org/10.1158/1055-9965.c.6515260.v1
https://doi.org/10.1158/1055-9965.c.6515260.v1
Autor:
Joel H. Rubenstein, Jennifer A. Burns, Maria E. Arasim, Elizabeth M. Firsht, Matthew Harbrecht, Marilla Widerquist, Richard R. Evans, John M. Inadomi, Joy W. Chang, William D. Hazelton, Chin Hur, Jacob E. Kurlander, Francesca Lim, Georg Luebeck, Peter W. Macdonald, Chanakyaram A. Reddy, Sameer D. Saini, Sarah Xinhui Tan, Akbar K. Waljee, Iris Lansdorp-Vogelaar
Publikováno v:
American Journal of Gastroenterology.
Autor:
Afrin N. Kamal, Chih-Hung Jason Wang, George Triadafilopoulos, David L. Diehl, Christopher DuCoin, Christy M. Dunst, Gary Falk, Prasad G. Iyer, David A. Katzka, Vani J.A. Konda, Raman Muthusamy, Fouad Otaki, Douglas Pleskow, Joel H. Rubenstein, Nicholas J. Shaheen, Prateek Sharma, Michael S. Smith, Joseph Sujka, Lee L. Swanstrom, Roger P. Tatum, Arvind J. Trindade, Michael Ujiki, Sachin Wani, John O. Clarke
Publikováno v:
Journal of Clinical Gastroenterology.
Publikováno v:
PLoS ONE, Vol 13, Iss 3, p e0195022 (2018)
Patients with inflammatory bowel disease(IBD) are frequently exposed to computed tomography (CT). Each CT exposes patients to radiation that cumulatively could increase the risk of malignancy, particularly in younger patients. We aim to study the eff
Externí odkaz:
https://doaj.org/article/2b328dea743f4e6a9e9e87e6d76bff76
Publikováno v:
The American Journal of Managed Care. 27:e413-e419
Use of anesthesia-assisted (AA) sedation for routine gastrointestinal (GI) endoscopy has increased markedly. Clinical uncertainty about which patients are most likely to benefit from AA sedation contributes to this increased use. We aimed to estimate